Edition:
United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.39USD
16 Feb 2018
Change (% chg)

$0.01 (+0.42%)
Prev Close
$2.38
Open
$2.36
Day's High
$2.40
Day's Low
$2.36
Volume
29,979
Avg. Vol
21,479
52-wk High
$7.15
52-wk Low
$2.00

Select another date:

Mon, Jan 29 2018

BRIEF-Pernix Announces Patent Litigation Settlement Agreement With Actavis

* PERNIX ANNOUNCES PATENT LITIGATION SETTLEMENT AGREEMENT WITH ACTAVIS CONCERNING ZOHYDRO® ER

BRIEF-Pernix Therapeutics Will Reduce Workforce By 41 Employees

* PERNIX THERAPEUTICS HOLDINGS INC - WILL REDUCE WORKFORCE BY 41 EMPLOYEES; MAJORITY EXPECTED TO BE WITH CO'S SALES FORCE & COMMERCIAL INFRASTRUCTURE

BRIEF-Pernix Therapeutics files for mixed shelf offering of up to $150 mln

* Pernix Therapeutics Holdings files for mixed shelf offering of up to $150 million - SEC filing‍​ Source text: (http://bit.ly/2jg0Ica) Further company coverage:

BRIEF-Pernix Therapeutics posts Q3 revenue of $40.5 mln

* Pernix Therapeutics reports third quarter 2017 financial results

BRIEF-Pernix Therapeutics announces sale of non-core product

* Pernix Therapeutics Holdings Inc - ‍sale of a non-core product Cedax to SI Pharmaceuticals LLC, for $2 million in gross cash proceeds​ Source text for Eikon: Further company coverage:

BRIEF-Pernix Therapeutics says CFO and president Graham Miao resigns

* Pernix Therapeutics announces planned departure of chief financial officer

Select another date: